Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  430,468 results for ""Dose-Response Relationship, Drug""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Subgroup-specific dose finding for phase I-II trials using Bayesian clustering.

  • Authors : Curtis A; Department of Biostatistics, University of Iowa, Iowa City, Iowa, USA.; Department of Statistics, Data and Analytics, Eli Lilly and Company, Indianapolis, Indiana, USA.

Subjects: Dose-Response Relationship, Drug* ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy; Bayes Theorem

  • Source: Statistics in medicine [Stat Med] 2022 Jul 20; Vol. 41 (16), pp. 3164-3179. Date of Electronic Publication: 2022 Apr 16.Publisher: Wiley Country of Publication: England NLM ID: 8215016 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0258

Record details

Read More Add to Saved list
×
Editorial & Opinion

The drug titration paradox: something obvious finally understood.

  • Authors : Egan TD; Department of Anesthesiology, University of Utah School of Medicine, Salt Lake City, UT, USA. Electronic address: .

Subjects: Dose-Response Relationship, Drug*; Humans

  • Source: British journal of anaesthesia [Br J Anaesth] 2022 Jun; Vol. 128 (6), pp. 900-902. Date of Electronic Publication: 2022 Apr 07.Publisher: Elsevier Country of Publication: England NLM ID: 0372541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-6771

Record details

Read More Add to Saved list
×
Academic Journal

A randomized study of the safety and pharmacokinetics of GSK3358699, a mononuclear myeloid-targeted bromodomain and extra-terminal domain inhibitor.

  • Authors : Brown JA; GlaxoSmithKline R&D, Cambridge, MA, USA.; Bal J

Subjects: Dose-Response Relationship, Drug*; Area Under Curve ; Cross-Over Studies

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 May; Vol. 88 (5), pp. 2140-2155. Date of Electronic Publication: 2021 Dec 18.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Single-dose of LC51-0255, a selective S1P 1 receptor modulator, showed dose-dependent and reversible reduction of absolute lymphocyte count in humans.

  • Authors : Won Lee S; Department of Clinical Pharmacology and Therapeutics, Hanyang University Seoul Hospital, Seoul, South Korea.; Hwang I

Subjects: Dose-Response Relationship, Drug*; Administration, Oral ; Double-Blind Method

  • Source: Clinical and translational science [Clin Transl Sci] 2022 Apr; Vol. 15 (4), pp. 1074-1083. Date of Electronic Publication: 2022 Jan 23.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Effect of corticosteroid dosing on outcomes in high-grade immune checkpoint inhibitor hepatitis.

  • Authors : Li M; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham & Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.

Subjects: Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/blood ; Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/diagnosis ; Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/drug therapy

  • Source: Hepatology (Baltimore, Md.) [Hepatology] 2022 Mar; Vol. 75 (3), pp. 531-540. Date of Electronic Publication: 2021 Dec 07.Publisher: Wiley Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3350

Record details

Read More Add to Saved list
×
Academic Journal

EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study.

  • Authors : Ratziu V; Sorbonne Université, ICAN, Hospital Pitié-Salpêtrière, INSERM UMRS 1138 CRC, Paris, France.; Rinella ME

Subjects: Dose-Response Relationship, Drug*; Non-alcoholic Fatty Liver Disease/Non-alcoholic Fatty Liver Disease/Non-alcoholic Fatty Liver Disease/*drug therapy ; Steroids/Steroids/Steroids/*administration & dosage

  • Source: Journal of hepatology [J Hepatol] 2022 Mar; Vol. 76 (3), pp. 506-517. Date of Electronic Publication: 2021 Nov 03.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacokinetics, Safety, and Tolerability of the α 2C -Adrenoreceptor Antagonist BAY 1193397 in Healthy Male Subjects.

  • Authors : Kapsa S; Clinical Pharmacokinetics, BAYER AG, Wuppertal, Germany.; Thuss U

Subjects: Dose-Response Relationship, Drug*; Administration, Oral ; Area Under Curve

  • Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2022 Mar; Vol. 11 (3), pp. 296-308. Date of ElectronicPublisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The antidepressant-like effect of resolvin E1 in repeated prednisolone-induced depression model mice.

  • Authors : Aoki S; Laboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-1192, Japan.; Deyama S

Subjects: Dose-Response Relationship, Drug*; Antidepressive Agents/Antidepressive Agents/Antidepressive Agents/*pharmacology ; Depression/Depression/Depression/*chemically induced

  • Source: Behavioural brain research [Behav Brain Res] 2022 Feb 10; Vol. 418, pp. 113676. Date of Electronic Publication: 2021 Nov 18.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 8004872 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

JQ1 attenuates psychostimulant- but not opioid-induced conditioned place preference.

  • Authors : Babigian CJ; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA.; Wiedner HJ

Subjects: Dose-Response Relationship, Drug*; Anesthetics, Local/Anesthetics, Local/Anesthetics, Local/*pharmacology ; Azepines/Azepines/Azepines/*administration & dosage

  • Source: Behavioural brain research [Behav Brain Res] 2022 Feb 10; Vol. 418, pp. 113644. Date of Electronic Publication: 2021 Oct 28.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 8004872 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Education level and misuse of antibiotics in the general population: a systematic review and dose-response meta-analysis.

  • Authors : Mallah N; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.; Department of Preventive Medicine, University of Santiago de Compostela, R/ San Francisco, s/n, 15782, Santiago de Compostela, Spain.

Subjects: Dose-Response Relationship, Drug* ; Educational Status*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use

  • Source: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2022 Feb 03; Vol. 11 (1), pp. 24. Date of Electronic Publication: 2022 Feb 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101585411 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-2994

Record details

Read More Add to Saved list
×
  • 1-10 of  430,468 results for ""Dose-Response Relationship, Drug""